Trial intelligence / Profile preview

Impact of Different Norepinephrine Doses on Accuracy of Peripheral Perfusion Index in Predicting Tissue Perfusion in Septic Shock Patients

NCT07330908Completed

Sponsor
Tanta University
Start
Oct 2024
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of norepinephrine in septic shock (2 arms), sponsored by Tanta University. Primary endpoint: Correlation between Peripheral Perfusion Index and Central venous oxygen saturation, and lactate clearance at 6 hours. Started Oct 2024; status: completed.

02

Drugs

norepinephrine
03

Conditions

septic shock

Beyond the preview

Go deeper on NCT07330908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07330908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call